Senior Vice-President, Head Immune-Oncology, Early Development and Translational Oncology, Pfizer
Chris Boshoff, M.D., Ph.D., FMedSci, is the head and senior vice president for immuno-oncology, early development and translational oncology at Pfizer, where he directs the strategies for early cancer drug development, precision medicine and immuno-oncology. Dr. Boshoff obtained his Ph.D. from the Institute of Cancer Research in London and trained as a medical oncologist at the Royal Marsden and Royal Free Hospitals in London. Before joining Pfizer in 2013, he was the director of the University College London (UCL) Cancer Institute (2007-2013). He was appointed adjunct professor at Yale University in 2014 and has published more than 150 original articles covering cancer biology, tumor virology and experimental cancer medicine.